Back to results
US 5,310,551 AGranted
Method for inhibiting pulmonary oxygen toxicity
AssigneeBoehringer Ingelheim Pharmaceuticals, Inc.
InventorsCraig D. Wegner, L. Gordon Letts
Life of this patent
Estimating the term…
Abstract
A method for inhibiting pulmonary oxygen toxicity in a patient requiring elevated levels of inhaled oxygen, by prophylactic administration of certain adhesion molecules and antibodies thereto.
Claims2
A method for reducing the severity of pulmonary oxygen toxicity in a patient susceptible thereto, which comprises prophylactically administering to the patient an agent selected from the group consisting of:
- a) an antibody capable of interfering with ICAM-1-dependent adhesion, by binding to ICAM-1;
- and
- b) a fragment of antibody (a), the fragment being capable of interfering with ICAM-1 dependent adhesion, by binding a ICAM-1.
Dependencies are inferred from the claim text.